About Careers MedBlog Contact us

Study Finds Forteo Drug to Be Effective for Osteoporosis

by VR Sreeraman on November 15, 2007 at 5:16 PM
Font : A-A+

Study Finds Forteo Drug to Be Effective for Osteoporosis

The drug Forteo has proven more effective than a rival drug in strengthening bones in arthritis patients suffering from osteoporosis, according to a US study published Wednesday.

The study by a researcher at the University of Alabama at Birmingham showed that Forteo enhanced the bone density of the lumbar spine by 7.2 percent compared to 3.4 percent for patients who used the drug Fosamax.


Forteo, manufactured by the firm Eli Lilly, also bolstered hip bone density by 3.8 percent during 28 months of treatment compared to 2.4 percent of patients using Fosamax, which is produced by Merck.

The clinical trial was carried out over 18 months on 428 men and women from age 22 to 89, said the study published in the latest issue of the New England Journal of Medicine. The bone density measurements were taken at the outset and end of the trial by a low-level x-ray machine.

Forteo is currently used to treat osteoporosis in post-menopausal women, who experience a drop in estrogen levels that causes the destruction of bone tissue.

The study will likely help Eli Lilly's bid for US government approval to use the drug to treat osteoporosis caused by glucocorticoid, a strong anti-inflammatory often prescribed to reduce swollen joints from arthritis.

Doctors currently recommend bisphosphonates, a category of drugs that includes Fosamax, to treat people with osteoporosis induced by glucocorticoid.

Experts hope that Forteo represents a new class of drugs that can bolster bone density as well as minimize the risk of fractures in arthritis patients, said the lead author of the study, Kenneth Saag, a professor in the university's division of clinical immunology and rheumatology.

Source: AFP


Recommended Reading

Latest Drug News

 Parkinson's Unmet Needs Creates Path for New Entrants into the Market
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
 Ivosidenib Approved for Acute Myeloid Leukemia & Advanced Cholangiocarcinoma
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
Sacubitril/valsartan Unleashes Hope for Heart Failure Patients
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Study Finds Forteo Drug to Be Effective for Osteoporosis Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests